Cargando…

Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening sequela of severe acute respiratory syndrome coronavirus 2 infection characterized by hyperinflammation and multiorgan dysfunction. Although hyperinflammation is a prominent manifestation of MIS-C, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Deepak, Rostad, Christina A., Jaggi, Preeti, Villacis Nunez, D. Sofia, Prince, Chengyu, Lu, Austin, Hussaini, Laila, Nguyen, Thinh H., Malik, Sakshi, Ponder, Lori A., Shenoy, Sreekala P.V., Anderson, Evan J., Briones, Michael, Sanz, Ignacio, Prahalad, Sampath, Chandrakasan, Shanmuganathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923010/
https://www.ncbi.nlm.nih.gov/pubmed/35304157
http://dx.doi.org/10.1016/j.jaci.2022.02.028
_version_ 1784669607810826240
author Kumar, Deepak
Rostad, Christina A.
Jaggi, Preeti
Villacis Nunez, D. Sofia
Prince, Chengyu
Lu, Austin
Hussaini, Laila
Nguyen, Thinh H.
Malik, Sakshi
Ponder, Lori A.
Shenoy, Sreekala P.V.
Anderson, Evan J.
Briones, Michael
Sanz, Ignacio
Prahalad, Sampath
Chandrakasan, Shanmuganathan
author_facet Kumar, Deepak
Rostad, Christina A.
Jaggi, Preeti
Villacis Nunez, D. Sofia
Prince, Chengyu
Lu, Austin
Hussaini, Laila
Nguyen, Thinh H.
Malik, Sakshi
Ponder, Lori A.
Shenoy, Sreekala P.V.
Anderson, Evan J.
Briones, Michael
Sanz, Ignacio
Prahalad, Sampath
Chandrakasan, Shanmuganathan
author_sort Kumar, Deepak
collection PubMed
description BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening sequela of severe acute respiratory syndrome coronavirus 2 infection characterized by hyperinflammation and multiorgan dysfunction. Although hyperinflammation is a prominent manifestation of MIS-C, there is limited understanding of how the inflammatory state of MIS-C differs from that of well-characterized hyperinflammatory syndromes such as hemophagocytic lymphohistiocytosis (HLH). OBJECTIVES: We sought to compare the qualitative and quantitative inflammatory profile differences between patients with MIS-C, coronavirus disease 2019, and HLH. METHODS: Clinical data abstraction from patient charts, T-cell immunophenotyping, and multiplex cytokine and chemokine profiling were performed for patients with MIS-C, patients with coronavirus disease 2019, and patients with HLH. RESULTS: We found that both patients with MIS-C and patients with HLH showed robust T-cell activation, markers of senescence, and exhaustion along with elevated T(H)1 and proinflammatory cytokines such as IFN-γ, C-X-C motif chemokine ligand 9, and C-X-C motif chemokine ligand 10. In comparison, the amplitude of T-cell activation and the levels of cytokines/chemokines were higher in patients with HLH when compared with patients with MIS-C. Distinguishing inflammatory features of MIS-C included elevation in T(H)2 inflammatory cytokines such as IL-4 and IL-13 and cytokine mediators of angiogenesis, vascular injury, and tissue repair such as vascular endothelial growth factor A and platelet-derived growth factor. Immune activation and hypercytokinemia in MIS-C resolved at follow-up. In addition, when these immune parameters were correlated with clinical parameters, CD8(+) T-cell activation correlated with cardiac dysfunction parameters such as B-type natriuretic peptide and troponin and inversely correlated with platelet count. CONCLUSIONS: Overall, this study characterizes unique and overlapping immunologic features that help to define the hyperinflammation associated with MIS-C versus HLH.
format Online
Article
Text
id pubmed-8923010
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-89230102022-03-15 Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH) Kumar, Deepak Rostad, Christina A. Jaggi, Preeti Villacis Nunez, D. Sofia Prince, Chengyu Lu, Austin Hussaini, Laila Nguyen, Thinh H. Malik, Sakshi Ponder, Lori A. Shenoy, Sreekala P.V. Anderson, Evan J. Briones, Michael Sanz, Ignacio Prahalad, Sampath Chandrakasan, Shanmuganathan J Allergy Clin Immunol Covid-19 BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening sequela of severe acute respiratory syndrome coronavirus 2 infection characterized by hyperinflammation and multiorgan dysfunction. Although hyperinflammation is a prominent manifestation of MIS-C, there is limited understanding of how the inflammatory state of MIS-C differs from that of well-characterized hyperinflammatory syndromes such as hemophagocytic lymphohistiocytosis (HLH). OBJECTIVES: We sought to compare the qualitative and quantitative inflammatory profile differences between patients with MIS-C, coronavirus disease 2019, and HLH. METHODS: Clinical data abstraction from patient charts, T-cell immunophenotyping, and multiplex cytokine and chemokine profiling were performed for patients with MIS-C, patients with coronavirus disease 2019, and patients with HLH. RESULTS: We found that both patients with MIS-C and patients with HLH showed robust T-cell activation, markers of senescence, and exhaustion along with elevated T(H)1 and proinflammatory cytokines such as IFN-γ, C-X-C motif chemokine ligand 9, and C-X-C motif chemokine ligand 10. In comparison, the amplitude of T-cell activation and the levels of cytokines/chemokines were higher in patients with HLH when compared with patients with MIS-C. Distinguishing inflammatory features of MIS-C included elevation in T(H)2 inflammatory cytokines such as IL-4 and IL-13 and cytokine mediators of angiogenesis, vascular injury, and tissue repair such as vascular endothelial growth factor A and platelet-derived growth factor. Immune activation and hypercytokinemia in MIS-C resolved at follow-up. In addition, when these immune parameters were correlated with clinical parameters, CD8(+) T-cell activation correlated with cardiac dysfunction parameters such as B-type natriuretic peptide and troponin and inversely correlated with platelet count. CONCLUSIONS: Overall, this study characterizes unique and overlapping immunologic features that help to define the hyperinflammation associated with MIS-C versus HLH. American Academy of Allergy, Asthma & Immunology 2022-05 2022-03-15 /pmc/articles/PMC8923010/ /pubmed/35304157 http://dx.doi.org/10.1016/j.jaci.2022.02.028 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19
Kumar, Deepak
Rostad, Christina A.
Jaggi, Preeti
Villacis Nunez, D. Sofia
Prince, Chengyu
Lu, Austin
Hussaini, Laila
Nguyen, Thinh H.
Malik, Sakshi
Ponder, Lori A.
Shenoy, Sreekala P.V.
Anderson, Evan J.
Briones, Michael
Sanz, Ignacio
Prahalad, Sampath
Chandrakasan, Shanmuganathan
Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
title Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
title_full Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
title_fullStr Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
title_full_unstemmed Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
title_short Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
title_sort distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (mis-c) versus hemophagocytic lymphohistiocytosis (hlh)
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923010/
https://www.ncbi.nlm.nih.gov/pubmed/35304157
http://dx.doi.org/10.1016/j.jaci.2022.02.028
work_keys_str_mv AT kumardeepak distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT rostadchristinaa distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT jaggipreeti distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT villacisnunezdsofia distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT princechengyu distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT luaustin distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT hussainilaila distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT nguyenthinhh distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT maliksakshi distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT ponderloria distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT shenoysreekalapv distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT andersonevanj distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT brionesmichael distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT sanzignacio distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT prahaladsampath distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh
AT chandrakasanshanmuganathan distinguishingimmuneactivationandinflammatorysignaturesofmultisysteminflammatorysyndromeinchildrenmiscversushemophagocyticlymphohistiocytosishlh